These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 5837278)

  • 21. Metabolism and binding of N-(2-methyl-6-methoxy-4-pyrimidinyl) sulfanilamide (sulfamethomidine) in man.
    DICARLO FJ; MALAMENT SG; HAYNES LJ; PHILLIPS GE
    Toxicol Appl Pharmacol; 1963 Jan; 5():61-70. PubMed ID: 14027680
    [No Abstract]   [Full Text] [Related]  

  • 22. Drug-induced hemolytic anemia.
    de LEEUW N; SHAPIRO L; LOWENSTEIN L
    Ann Intern Med; 1963 Apr; 58():592-607. PubMed ID: 13929214
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the protein-binding of long-acting sulfonamides].
    SCHOLTAN W
    Chemotherapia (Basel); 1963; 6():180-95. PubMed ID: 13992327
    [No Abstract]   [Full Text] [Related]  

  • 24. BINDING CAPABILITY OF VARIOUS SULFONAMIDES TO SERUMS OF DIFFERENT ANIMAL SPECIES.
    GENAZZANI E; PAGNINI G
    Am J Vet Res; 1963 Nov; 24():1212-6. PubMed ID: 14081457
    [No Abstract]   [Full Text] [Related]  

  • 25. [A comparative study of the interference of sulfamides in peptone media. A concept concerning the masking of sulfamide sensitivity by peptones].
    Marica D; Ordeanu V; Ciocîrlie I; Iordăchescu I; Trăşculescu S; Răpunteanu G; Buia E; Agapi D; Constantinescu C
    Bacteriol Virusol Parazitol Epidemiol; 1992; 37(1-2):81-6. PubMed ID: 1472784
    [No Abstract]   [Full Text] [Related]  

  • 26. Diffusion of sulfonamides in aqueous buffers and into red cells.
    Holder LB; Hayes SL
    Mol Pharmacol; 1965 Nov; 1(3):266-79. PubMed ID: 5842825
    [No Abstract]   [Full Text] [Related]  

  • 27. [Calculations of molecular orbit. 3. Electronic density of sulfas by the omega technic].
    Korolkovas A; Tamashiro K
    Rev Farm Bioquim Univ Sao Paulo; 1974; 12(1):37-51. PubMed ID: 4467253
    [No Abstract]   [Full Text] [Related]  

  • 28. [In vitro sensitivity of the sulfonamides against atypical Mycobacteria (author's transl)].
    Hokama S
    Kekkaku; 1976 Jul; 51(7):287-91. PubMed ID: 966409
    [No Abstract]   [Full Text] [Related]  

  • 29. An automated method for the determination of sulfonamides in plasma.
    Falk HB; Kelly RG
    Clin Chem; 1965 Dec; 11(12):1045-50. PubMed ID: 5898037
    [No Abstract]   [Full Text] [Related]  

  • 30. [Increase in albumin binding of promazine, depending on other drugs].
    Krieglstein J; Franz JW; Jähnchen E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):261. PubMed ID: 4242407
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-acting sulfonamides in cattle: a study of pharmacologic properties.
    Silvestri R; Magnifico P; Glatstein S
    Am J Vet Res; 1967 Nov; 28(127):1783-97. PubMed ID: 6076565
    [No Abstract]   [Full Text] [Related]  

  • 32. Long-acting and short-acting sulfonamides. Recent developments.
    Struller T
    Antibiot Chemother; 1968; 14():179-215. PubMed ID: 4883637
    [No Abstract]   [Full Text] [Related]  

  • 33. New Ni(II)-sulfonamide complexes: synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4].2H2O and [Ni(sulfapyridine)2].
    Mondelli M; Bruné V; Borthagaray G; Ellena J; Nascimento OR; Leite CQ; Batista AA; Torre MH
    J Inorg Biochem; 2008 Feb; 102(2):285-92. PubMed ID: 17976730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new sulfonamide combination designed for treatment of kidney and urinary tract infections: its blood concentration and renal excretion.
    HOLMGARD A; JOSEPHSON B; BUCHT H; ORSTEN PA
    Curr Ther Res Clin Exp; 1961 Sep; 3():397-404. PubMed ID: 13715486
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the effect of peptones of various origins on the result of the bacteriostasis test].
    Weuffen W; Pluschkat H; Pahlke U
    Z Gesamte Hyg; 1967 Sep; 13(9):677-80. PubMed ID: 5618565
    [No Abstract]   [Full Text] [Related]  

  • 36. Prediction of in vivo drug-drug interactions between tolbutamide and various sulfonamides in humans based on in vitro experiments.
    Komatsu K; Ito K; Nakajima Y; Kanamitsu Si; Imaoka S; Funae Y; Green CE; Tyson CA; Shimada N; Sugiyama Y
    Drug Metab Dispos; 2000 Apr; 28(4):475-81. PubMed ID: 10725317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Physicochemical and biological studies on sulfonamides. 2. Protein-binding, pharmacokinetics and distribution of 5 sulfonamides in rabbits].
    RIEDER J
    Arzneimittelforschung; 1963 Feb; 13():89-95. PubMed ID: 13982262
    [No Abstract]   [Full Text] [Related]  

  • 38. [On the ratio of the binding of various long-acting sulfa drugs to plasma proteins].
    HASUMURA N; NAKAMURA K
    Sogo Igaku; 1962 Dec; 19():911-3. PubMed ID: 13960929
    [No Abstract]   [Full Text] [Related]  

  • 39. Warning against prolonged-action sulfonamides.
    Med Lett Drugs Ther; 1966 Feb; 8(4):13-4. PubMed ID: 5907884
    [No Abstract]   [Full Text] [Related]  

  • 40. Some pharmacologic properties of sulfamethoxpyridazine and a new sulfonamide, sulfapyrazinemethoxyne, in calves.
    FAUSTINI R; VAGHI MA
    Am J Vet Res; 1962 Jan; 23():58-63. PubMed ID: 13891828
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.